(Q77613940)

English

Comparative in vitro activity of meropenem versus other routinely used antimicrobials against 18632 aerobic bacteria tested in 92 German centers

scientific article published on 01 August 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Comparative in vitro activity of meropenem versus other routinely used antimicrobials against 18632 aerobic bacteria tested in 92 German centers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

based on heuristic

inferred from title

author name string

H K Geiss

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Beck

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

237-243

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900044-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900044-2

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro studies of meropenem

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900044-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900044-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900044-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900044-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900044-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900044-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Major trends in the microbial etiology of nosocomial infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900044-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(98)00044-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9832285%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77613940&oldid=1685023321"